共 50 条
- [4] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial Cardiology and Therapy, 2020, 9 : 535 - 540
- [9] Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (05) : 529 - 538
- [10] Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10